Izhar Bagwan
Overview
Explore the profile of Izhar Bagwan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
375
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sherif O, Khelwatty S, Bagwan I, Seddon A, Dalgleish A, Mudan S, et al.
Oncol Rep
. 2024 Oct;
52(6).
PMID: 39450530
The aberrant expression of HER family members and cancer stem cells (CSCs) have been associated with tumour progression and resistance to therapy. At present, several HER inhibitors have been approved...
2.
Al-Janaby T, Nahi N, Seddon A, Bagwan I, Khelwatty S, Modjtahedi H
World J Oncol
. 2024 Mar;
15(2):192-208.
PMID: 38545471
Background: Of various human epidermal growth factor receptor (HER) inhibitors, only the anti-HER2 monoclonal antibody (mAb) Herceptin/trastuzumab and the antibody-drug conjugate trastuzumab deruxtecan (T-Dxd) has been approved for the treatment...
3.
Julve M, Kennedy O, Frampton A, Bagwan I, Lythgoe M
J Clin Pathol
. 2023 Oct;
77(1):1-7.
PMID: 37857483
Cancer testis antigen gene 1B (CTAG1B) and its associated gene product; New York oesophageal squamous carcinoma 1 (NY-ESO-1), represent a unique and promising target for cancer immunotherapy. As a member...
4.
Algudkar A, Harrington K, Kerawala C, Bagwan I, Ap Dafydd D
Oral Maxillofac Surg
. 2023 Apr;
28(1):363-372.
PMID: 37020144
Purpose: Awareness of head and neck mucosal melanoma (HNMM) is important, as incorrect work-up can impact on the investigation and management of this rare and aggressive cancer. Following on from...
5.
Kronsten V, Gosson C, Al-Khatib A, Bagwan I, Worthington T, Muthalali S, et al.
ACG Case Rep J
. 2022 Jul;
9(7):e00824.
PMID: 35811577
Enteropathy-associated T-cell lymphoma (EATL) is a rare but serious complication of celiac disease. Diagnosis is challenging. Patients can present with weight loss, abdominal pain, and diarrhea or acutely with bowel...
6.
Warnick J, Lahiri R, Karanjia N, Fisher C, Bagwan I
Int J Surg Pathol
. 2022 May;
31(3):307-311.
PMID: 35611498
Liposarcoma is the most common malignant soft tissue tumour in adults occurring predominantly in the retroperitoneum and extremities but very rarely within the gastrointestinal tract. We report on a 77-year-old...
7.
Arunachalam E, Rogers W, Simpson G, Moller-Levet C, Bolton G, Ismael M, et al.
BMC Cancer
. 2022 Apr;
22(1):400.
PMID: 35418059
Background: Glioblastoma multiforme (GBM) is the most common high-grade malignant brain tumour in adults and arises from the glial cells in the brain. The prognosis of treated GBM remains very...
8.
Martinou E, Moller-Levet C, Karamanis D, Bagwan I, Angelidi A
Int J Mol Sci
. 2022 Feb;
23(4).
PMID: 35216396
As is known, HOXB9 is an important factor affecting disease progression and overall survival (OS) in cancer. However, its role in colorectal cancer (CRC) remains unclear. We aimed to explore...
9.
Merali N, Chouari T, Kayani K, Rayner C, Jimenez J, Krell J, et al.
Cancers (Basel)
. 2022 Feb;
14(4).
PMID: 35205769
Pancreatic ductal adenocarcinoma (PDAC) is expected to become the second most common cause of cancer death in the USA by 2030, yet progress continues to lag behind that of other...
10.
Martinou E, Falgari G, Bagwan I, Angelidi A
Int J Mol Sci
. 2021 Dec;
22(24).
PMID: 34948228
Emerging evidence shows that Homeobox () genes are important in carcinogenesis, and their dysregulation has been linked with metastatic potential and poor prognosis. This review (PROSPERO-CRD42020190953) aims to systematically investigate...